Decoding Diabetic Kidney Disease
A research team at the Icahn School of Medicine at Mount Sinai has revealed biological pathways involved in diabetic kidney disease. They hope that with these new pathways, early diagnostic tests and targeted treatments can be designed. According to the National Kidney Foundation, about 30 percent of patients with type 1 diabetes and 10 to 40 percent of those with type 2 diabetes will eventually have end-stage renal disease (ESRD).